There are increasing evidences that tumor-derived soluble factors promote the induction of tolerance through the generation of CD4+ CD25highFoxp3+ Treg subset, which is linked to compromised immune responses in patients with advanced cancer [120]. The gene discussed is CD4; the disease is neoplasm.